MyMD Pharmaceuticals grants 750,000 stock options to President and CMO Chris Chapman

Q/C TECHNOLOGIES, INC.

Grant of options to purchase 750,000 shares at $1.55 per share to Dr. Chris Chapman, President and CMO.
Options vest in three equal annual installments starting April 4, 2023.
Options expire on fifth anniversary of grant date (April 4, 2028).
Grant approved by compensation committee on April 4, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.